Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin in Long-term Meditators
NCT02145091Phase 1Completed
- Sponsor
- Johns Hopkins University
- Start
- May 2014
- Primary completion
- Dec 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of psilocybin (4 arms), sponsored by Johns Hopkins University. Primary endpoints: Persisting Effects Questionnaire, Hood Mysticism Scale and 2 more. Started May 2014; status: completed.
02
Drugs
psilocybin
Beyond the preview
Go deeper on NCT02145091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02145091.